<DOC>
	<DOCNO>NCT01675050</DOCNO>
	<brief_summary>The investigator hypothesize use Cyproheptadine placebo-controlled crossover trial would help relieve abdominal pain associate FAP child , achieve great response observe placebo . In addition assess self-report pain symptom , investigator also propose perform experimental somatic pain test determine evidence peripherally-maintained central sensitization child FAP . The investigator also hypothesize increase somatic pain threshold completion Cyproheptadine course compare baseline test prior treatment , compare placebo . This would allow child FAP return normal function , improve symptom overall general well-being</brief_summary>
	<brief_title>A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal Pain</brief_title>
	<detailed_description />
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Cyproheptadine</mesh_term>
	<criteria>Age 8 18 yearsold Diagnosed Functional Abdominal Pain use Rome III Criteria must include all* follow : 1 . Episodic continuous abdominal pain 2 . Insufficient criterion FGIDs 3 . No evidence inflammatory , anatomic , metabolic , neoplastic process explain subject 's symptom Criteria fulfil least per week least 2 month prior diagnosis Written inform consent obtain patient/guardian initiation studyspecific procedure Age &lt; 8 yearsold Age &gt; 18 yearsold Child parent nonEnglish speaker Child use CNS depressant ( cyproheptadine cause drowsiness , may enhance adverse/toxic effect CNS Depressants e.g . opioids , barbiturate , Droperidol , Hydroxyzine , Alcohol ) ( 29 ) Child history hypersensitivity Cyproheptadine product Child currently use monoamine oxidase inhibitor ( MAOI e.g . Nardil , Marplan , Parnate ) ( cause prolong intensified anticholinergic effect ) Child treat Cyproheptadine past 4 week Child currently use anticholinergic ( cause additive anticholinergic effect e.g . Pramlintide ) Concomitant SSRI use ( serotonin antagonist , may oppose effect ) Concomitant use Betahistine : Antihistamines may diminish therapeutic effect Betahistine Concomitant use Acetylcholinesterase Inhibitors ( Central ) : Anticholinergics may diminish therapeutic effect Acetylcholinesterase Inhibitors ( Central ) vice versa . Child personal history glaucoma Child asthma ( cause thicken bronchial secretion ) ( 27,28 ) History liver dysfunction/disease ( cause hepatitis ) History cardiac disease ( specific Cyproheptadine , antihistamine associate hypotension , palpitation , tachycardia arrhythmia ) ( 28,29 ) . Females know pregnant also exclude . All female child bear age , already menstruate perform urine pregnancy test enrol . Any child difficulty swallow tablet receive teach swallow tablet . If still unable , participate study .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>